Donate securely now to support GI research

My Cart | Register | Sign In

Header Image

Industry Sponsored Clinical Trials and Studies


A clinical study or trial is a research study to answer specific questions about new therapies or new ways of using known treatments. Clinical studies/trials test potential treatments in human volunteers to see if they should be approved for wider use in the general population.

Why Participate in a Clinical Trial?

Participants in clinical trials can play a more active role in their own health care, gain access to new research treatments before they are widely available, and help others by contributing to medical research. (Find out more including answers to frequently asked questions in this Guide to Randomized Clinical Trials.)

Trials Seeking Participants

Two Double-blind,Randomized, Placebo-controlled, Phase 3 Trials in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg

Purpose of the study 1: 26 Week Efficacy and Safety Trial for Patients with Chronic Idiopathic Constipation

Sponsored by: Ferring Pharmaceuticals

Participation: Eligible male and female patients aged 18 years or older

Contacts: Clinical Development Support, Email: DK0-Disclosure@ferring.com

 

Purpose of the study 2: 12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients with Chronic Idiopathic Constipation

Sponsored by: Ferring Pharmaceuticals

Participation: Eligible male and female patients aged 18 years or older

Contacts: Clinical Development Support, Email: DK0-Disclosure@ferring.com

A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)

This trial is ongoing, but no longer seeking participants.

Purpose of the study: This study will evaluate the effectiveness and safety of repeat treatment with rifaximin 550 mg three times a day in patients with IBS with diarrhea who respond to initial treatment of rifaximin 550 mg three times a day.

Sponsored by: Salix Pharmaceuticals, Inc.

Participation: Eligible male and female patients aged 18 years and older with a diagnosis of irritable bowel syndrome (IBS) with a subtype of diarrhea.

Contacts: Rachel Ballard, email: rachel.ballard@salix.com; or Alyson Lineberry, email: alyson.lineberry@salix.com

Last modified on September 20, 2014 at 06:42:06 PM